Evidence map›Paper›PMID 26398706›Full record

ArticleInternational journal of oncology2015

Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin.

Chong-Zhi Wang, Chun-Feng Zhang, Lina Chen, Samantha Anderson, Fang Lu, Chun-Su Yuan

Abstract read
In one paragraph

Article in International journal of oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chong-Zhi WangΤang Center for Herbal Medicine Research, University of Chicago, Chicago, IL 60637, USA.
Chun-Feng ZhangΤang Center for Herbal Medicine Research, University of Chicago, Chicago, IL 60637, USA.
Lina ChenΤang Center for Herbal Medicine Research, University of Chicago, Chicago, IL 60637, USA.
Samantha AndersonΤang Center for Herbal Medicine Research, University of Chicago, Chicago, IL 60637, USA.
Fang LuΤang Center for Herbal Medicine Research, University of Chicago, Chicago, IL 60637, USA.
Chun-Su YuanΤang Center for Herbal Medicine Research, University of Chicago, Chicago, IL 60637, USA.

Funding

Center for Herbal Research on Colorectal CancerP01AT004418 · NCCIH · UNIVERSITY OF CHICAGO · PI YUAN, CHUN-SU · 2008 to 2012
$5.9M
Chemoprevention of Active Scutellaria baicalensis Fraction on Colon CancerK01AT005362 · NCCIH · UNIVERSITY OF CHICAGO · PI WANG, CHONG-ZHI · 2010 to 2014
$486k
NCCIH NIH HHS K01 AT005362NCCIH NIH HHS P01 AT004418
6 · The paper itself

Abstract

Baicalin is a major constituent of Scutellaria baicalensis, which is a commonly used herbal medicine in many Asian countries. After oral ingestion, intestinal microbiota metabolism may change parent compound's structure and its biological activities. However, whether baicalin can be metabolized by enteric microbiota and the related anticancer activity is not clear. In this study, using human enteric microbiome incubation and HPLC analysis, we observed that baicalin can be quickly converted to baicalein. We compared the antiproliferative effects of baicalin and baicalein using a panel of human cancer cell lines, including three human colorectal cancer (CRC) cell lines. In vitro antiproliferative effects on CRC cells were verified using an in vivo xenograft nude mouse model. Baicalin showed limited antiproliferative effects on some of these cancer cell lines. Baicalein, however, showed significant antiproliferative effects in all the tested cancer cell lines, especially on HCT-116 human colorectal cancer cells. In vivo antitumor results supported our in vitro data. We demonstrated that baicalein exerts potent S phase cell cycle arrest and pro-apoptotic effects in HCT-116 cells. Baicalein induced the activation of caspase 3 and 9. The in silico modeling suggested that baicalein forms hydrogen bonds with residues Ser251 and Asp253 at the active site of caspase 3, while interactions with residues Leu227 and Asp228 in caspase 9 through its hydroxyl groups. Data from this study suggested that baicalein is a potent anticancer metabolite derived from S. baicalensis. Enteric microbiota play a key role in the colon cancer chemoprevention of S. baicalensis.

Indexed as

Gastrointestinal MicrobiomeAnimalsApoptosisCell CycleCell ProliferationColonic NeoplasmsFlavanonesFlavonoidsHCT116 CellsHumansMicePhytotherapyPlant ExtractsScutellaria baicalensisbaicaleinbaicalinFlavanonesFlavonoidsPlant ExtractsScutellaria baicalensis extract

Identifiers

PMID26398706
PMCPMC4599184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.